NCT06133140

Continuous Ward Monitoring With the GE Portrait Mobile Monitoring Solution: the COSMOS Trial

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 227 (actual)
• Sponsor: The Cleveland Clinic · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The investigators plan to determine whether unblinded continuous ward monitoring with the GE Portrait Mobile Monitoring Solution and nursing alerts reduces vital sign abnormalities in patients recovering from major noncardiac surgery.

Detailed description

Primary Aim. Determine whether unblinded continuous ward monitoring with the GE Portrait Mobile Monitoring Solution and nursing alerts reduces vital sign abnormalities in patients recovering from major noncardiac surgery. Primary hypothesis. Unblinded continuous ward monitoring and nurse alerts reduces vital sign abnormalities during the initial 48 postoperative hours after major non-cardiac surgery while patients remain hospitalized. Secondary Aim. Determine whether continuous ward saturation, ventilation, and pulse rate monitoring reduces a composite of substantive respiratory and cardiovascular interventions. Secondary hypothesis. Unblinded continuous ward monitoring increases a composite of clinical interventions for desaturation, hypoventilation, tachypnea, tachycardia, and bradycardia within 48 hours after major non-cardiac surgery.

Conditions

• Postoperative Complications

Interventions

Type	Name	Description
DEVICE	Unblinded postoperative vital sign monitoring	Unblinded postoperative GE Portrait monitoring
DEVICE	Blinded postoperative vital sign monitoring	Blinded postoperative GE Portrait monitoring

Timeline

• Start date: 2024-02-14
• Primary completion: 2026-01-01
• Completion: 2026-01-06
• First posted: 2023-11-15
• Last updated: 2026-01-09

Locations

1 site across 1 country: United States